期刊文献+

米索前列醇不同给药途径用于绝经后妇女取器的临床效果观察 被引量:10

Clinical effect of misoprostol in different administration for the cervical preparation of postmenopausal women before removing intrauterine device
下载PDF
导出
摘要 目的:探讨米索前列醇不同给药途径用于绝经后取出宫内节育器的临床效果。方法:选取自愿要求取器的绝经后健康妇女168例,随机分为3组,分别于术前3h一次性口服、舌下分次含服和阴道穹隆放置米索前列醇0.6mg,观察临床效果。结果:宫颈软化、术中疼痛、术中出血情况和取器时间3组差异无统计学意义(P>0.05);用药后恶心呕吐、腹痛腹泻发生率口服组(39.3%30.4%)高于舌下含服(5.3%,5.3%)和阴道放置组(1.8%,7.1%)(P<0.05);发热寒战、头痛头晕、手心瘙痒等副作用发生率口服组(26.8%,8.9%,32.1%)和舌下含服组(26.8%,8.9%,33.9%)高于阴道置药组(1.8%,0,1.8%)(P<0.05)。结论:阴道穹隆放置米索前列醇是绝经后取器术前的宫颈准备的一种有效、安全的用药途径。 Objective:To study the clinical effect of misoprostol in different administration for the cervical preparation of postmenopausal women before removing intrauterine device(IUD).Methods:168 postmenopausal and health women who voluntary required to remove IUD were divided into three groups.3 hours before operation,the women in group A were given 0.6 mg misoprostol oral,the women in group B were given 0.6 mg misoprostol under the tongue,and the women in group C were given 0.6 mg misoprostol in vagina.The clinical effect of women were observed and compared.Results:There were no statistical significant different in the cervical softening degree,intraoperative pain degree,operative time and intraoperative bleeding volume among the three groups(P>0.05).The rate of gastrointestinal side effects of women in group A was significant higher than that of women in group B and C(P<0.05),and the rates of chills,fever,headache,dizziness and itchy hands of women in group A and group B were significant higher than those of women in group C(P<0.05).Conclusion:The misoprostol given in vagina for the cervical preparation of postmenopausal women before removing IUD is effective and safety.
作者 曹任敏 CAO Renmin(Tongzhou District Maternal and Child Health Care and Family Planning Service Center,Nantong City,Jiangsu Province,226300)
出处 《中国计划生育学杂志》 2019年第7期949-951,共3页 Chinese Journal of Family Planning
关键词 绝经妇女 宫内节育器 米索前列醇 给药途径 Postmenopausal women Intrauterine device Misoprostol Route of administration
  • 相关文献

参考文献5

二级参考文献45

  • 1商寿玲,谢国华,张钰娟,王建梅,霍彦,李奕.舌下含服米索前列醇在无痛人工流产术中的作用[J].中国计划生育学杂志,2004,12(9):548-550. 被引量:22
  • 2乌毓明.药物流产并发症的防治[J].实用妇产科杂志,2006,22(2):70-71. 被引量:43
  • 3李奕,张钰娟,商寿玲,霍彦,张钰.米索前列醇舌下给药对药物流产的作用研究[J].天津医药,2006,34(5):311-313. 被引量:8
  • 4周玮,刘建,孙江川,杨锡蒂.米索前列醇治疗剖宫产术后宫腔积血的临床观察[J].中国实用妇科与产科杂志,2006,22(10):771-772. 被引量:46
  • 5Singh K,fong YF,Prased RN, et al. Vaginal misoprostol for preabor- tion cervical Priming: is there an optional evacuation time interai? I J 1. Br J Obstet Gyneecol, 1999,106 ( 3 ) :266 - 269.
  • 6Tang OS, Schweer H, Seyberth HW, eta]. Pharmacokinetics of dif- feront routes of administration of misoproatolIJ]. Hum Reprod,2002, 17(2) :332-336.
  • 7Margulies M, Rerez GC, Voto LS. Misopristol to induce labor[J]. The Lancet, 1992,339(8 784) :64.
  • 8Ngal SW, Yeung KC, Lao T, et al. Oral misoprostolver- sus vaginal gemeprost for cervical dilation prior to vacu- umas piration in women in the sixth to twelfth week of gestation[J]. Contraception, 1995,51(6) : 347.
  • 9Wing DA, Park MR, Paul RH. A randomized comparison of oral an intravaginal misoprostol for labor induction[J]. Obstet Gynecol, 2000,95(6) :905.
  • 10Saxena P, Saihan S, Sarda N. Comparison between the sub lingual and oral route of misoprostol for preaboction cervical priming in first trimester abortions[J]. Hum Re- ported, 2004,19(1) : 77.

共引文献75

同被引文献100

引证文献10

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部